GLP-1 medications address appetite regulation and insulin sensitivity
I think that RFK and the [Make America Healthy Again] movement see peptides as part of a suite of compounds that, as they see it, have been kind of improperly restricted by the pharmaceutical industry
A., Koppolu, P., Chakrabarti, S
The question is whether semaglutide belongs in this category
[2] This is the highest tier of evidence in this entire comparison: randomized, blinded, placebo-controlled, with a hard imaging endpoint (visceral fat measured by CT), replicated across two trials, and reviewed by a regulator
Meet the experts : Dharti Dua, MD, neurologist and clinical assistant professor at The Ohio State University Wexner Medical Center and College of Medicine